Cobalt Blue Holdings Limited ('COB') said today that its Mixed Hydroxide Product testwork delivers a premium product. See the copy of COB's ASX Market Update below:
KEY POINTS
1. Significant testwork outcome – strong hydroxide results ~37% cobalt and ~7% nickel content with low impurities = a premium product.
2. Large scale furnace work scheduled for May 2020.
3. Pilot Plant – expecting commissioning Q4 2020.
4. Ore Reserve Statement update on track for mid-year release.
Given Havilah's Mutooroo Copper-Cobalt-Gold Project is only a few kilometres away from COB's Broken Hill Cobalt Project in New South Wales, I continue to hope that COB does crack the technique for extracting sulphur and cobalt on a commercial scale.
If COB's cobalt extraction process works, it will potentially make Havilah's 100% owned Mutooroo Copper-Cobalt-Gold Project that much more valuable.
In my opinion, the Mutooroo Copper-Cobalt-Gold Project provides Havilah shareholders with significant leverage to current high gold prices and anticipated future improved copper and cobalt prices based on the likely increased demand associated with the worldwide move to 'electrification of transport' and the 'decarbonisation of stationary power.
Cheers
These are only my thoughts and it does not constitute investment advice. Before acting on any information you read and before making any financial or investment decisions, you should always consult your advisor(s) or other relevant professional experts.
- Forums
- ASX - By Stock
- HAV
- Ann: Cobalt Recovery Initiative with Cobalt Blue
Ann: Cobalt Recovery Initiative with Cobalt Blue, page-45
Featured News
Add HAV (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.0¢ |
Change
-0.010(4.55%) |
Mkt cap ! $66.49M |
Open | High | Low | Value | Volume |
22.0¢ | 22.0¢ | 21.0¢ | $19.43K | 91.51K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1756 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 12400 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1756 | 0.210 |
2 | 104877 | 0.205 |
2 | 150000 | 0.200 |
2 | 100260 | 0.195 |
2 | 24330 | 0.190 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 12400 | 2 |
0.240 | 36005 | 4 |
0.245 | 19085 | 2 |
0.250 | 28500 | 3 |
0.255 | 25000 | 1 |
Last trade - 14.54pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
21.0¢ |
  |
Change
-0.010 ( 2.33 %) |
|||
Open | High | Low | Volume | ||
21.0¢ | 21.0¢ | 21.0¢ | 26796 | ||
Last updated 14.10pm 06/05/2024 ? |
Featured News
HAV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online